🗂️ Portfolio 1
44 analysts rated MU in the last 30 days, with 13 Strong Buy, 15 Buy, 5 Hold, 10 Sell and 1 Strong Sell, making this one of the most divided windows across the portfolio. The most recent article, by Scott Gossett on 2026-04-22 at Buy in 'Micron: A Study Of Event Returns, Regime Tailwinds, And DRAM ASP', argues post-earnings weakness fits historical patterns rather than a fundamental shift, and applies an 8x forward P/E to derive a 12-month fair value of $900 per share, with AI hyperscaler CapEx and resilient DRAM pricing underpinning the thesis. The large bearish bloc is anchored by Tech Stock Pros at Sell on 2026-04-20 in 'Micron: Dead Cats Don't Bounce Twice', making MU the highest-dispersion name in the current window with 28 bullish versus 11 bearish analysts.
10 analysts rated COHR in the last 30 days, with 3 Strong Buy, 6 Buy, 1 Hold and 0 Sell. Himalayas Research rated Buy on 2026-04-22 in 'Coherent: A Buy Driven By Robust AI Datacenter Optics Demand', projecting revenue to compound from $5.8 billion in FY2025 to $10.6 billion by FY2028 with EPS growing at a 45% CAGR, supported by a 6-inch InP wafer transition and a new Apple supply deal. On 2026-04-21, KM Capital also rated Buy in 'Coherent: A Cautious Buy Despite Hefty Valuation', noting shares are up 88% year-to-date and that Nvidia's $2 billion investment partnership and 34% year-over-year Datacenter segment growth justify the elevated multiple. The lone Hold in the window reflects valuation caution, but the nine-of-ten Buy or Strong Buy consensus reflects strong conviction in COHR's AI optics positioning.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 18 analysts: 5 Strong Buy · 5 Buy · 5 Hold · 2 Sell · 1 Strong Sell.
24 analysts rated Marvell in the last 30 days, with 3 Strong Buy, 17 Buy and 4 Hold. Both captured articles are dated 2026-04-21 and disagree: the Buy carries a $200 FY27 target on EBIT margins above 20%, potential Alphabet chip collaborations and recent XConn and Celestial acquisitions, while the Hold argues custom silicon/XPU growth guidance of just 20% for FY27 and a 36.5x forward P/E roughly in line with Broadcom don't justify a bullish stance. The breakdown overall is heavily tilted to buys with no Sells.
7 analysts rated LUNR in the last 90 days, with 0 Strong Buy, 5 Buy, 2 Hold and 0 Sell. The most recent article, by Byte Sized Alpha on 2026-04-21 at Buy in 'Intuitive Machines: From Lunar Lander To Space Infrastructure Play', sets a 12-month price target of $34.94, arguing the company is transitioning to recurring revenue via the $4.82 billion NASA NSNS contract and the $800 million Lanteris acquisition that expands LUNR into national security. Management guides to nearly 5x revenue growth in 2026, a $943 million backlog, and expected positive adjusted EBITDA, marking an inflection toward profitability. The two Hold-rated analysts in the window acknowledge the contract wins but are more cautious on execution and valuation at current levels.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 12 analysts: 3 Strong Buy · 7 Buy · 2 Hold.
25 analysts rated Celestica in the last 30 days, with 7 Strong Buy, 14 Buy and 4 Hold. No article bodies landed this run, but the breakdown is strongly constructive: 21 of 25 ratings sit in the buy bucket with no Sells at all, keeping conviction Very Strong.
15 analysts rated AMD in the last 30 days, with 5 Strong Buy, 4 Buy, 5 Hold, 1 Sell and 0 Strong Sell. The most recent call is Kumquat Research on 2026-04-21 at Strong Buy in 'AMD Stock: My $300 Target Is Close - Here's What Comes Next', arguing that AMD shares have risen 40% in a month and that CPU shortages combined with AI data center momentum will carry shares higher into the second half of 2026. Stone Fox Capital also holds a Strong Buy via 'AMD: $600 Bullseye', while JR Research moved to Hold on 2026-04-20 in 'AMD: Don't Chase Now, Even If You Missed The Ride (Downgrade)', cautioning against chasing at elevated prices. The 5-Hold and 1-Sell minority reflects meaningful dispersion against the 9 bullish calls.
32 analysts rated MSFT in the last 30 days, with 10 Strong Buy, 13 Buy, 7 Hold and 2 Sell. The most recent article, by Konstantinos Kosmidis on 2026-04-21 at Buy in 'Microsoft's Bear Case Is Hard To Buy', argues MSFT trades at 25.1x forward earnings well below its 10-year median, with fears over AI CapEx ROI and agentic disruption overstated, setting up a potential major rerating; Q2 2026 showed strong revenue and income growth though free cash flow declined and CapEx surged to $37.5 billion. The minority bear case is represented by Dmytro Lebid at Sell on 2026-04-17 in 'Microsoft: Don't Buy The Dip; A 30% Correction Is Still Ahead', providing a direct counter to the dominant 23-analyst bullish camp.
30 analysts rated NVDA in the last 30 days, with 11 Strong Buy, 10 Buy, 4 Hold, 3 Sell and 2 Strong Sell. The most recent article, by Justin Purohit on 2026-04-21 at Hold in 'Nvidia: Shifting Competitive Landscape, Shares A Hold', acknowledges Nvidia's AI market leadership but flags increasing competitive threats as the key long-term risk, noting Wall Street's consensus fair value near $270 per share implying roughly 35% upside from current prices. In contrast, Joseph Parrish upgraded to Buy on 2026-04-16 in 'Nvidia: I'm Finally Convinced (Rating Upgrade)', while Elizabeth Pramila holds a Strong Sell from 2026-04-15 in 'Nvidia And AMD: Trim Your Hare, Buy A Tortoise', illustrating significant dispersion across the 5 non-bullish calls against the 21-analyst bullish majority.
33 analysts rated Tesla in the last 30 days, with 2 Strong Buy, 7 Buy, 6 Hold, 7 Sell and 11 Strong Sell, a clearly bearish breakdown. The only captured article, a 2026-04-21 Sell, argues the upcoming SpaceX IPO will divert Musk-focused capital, highlights a ~50,000-unit production-delivery gap, flags automotive gross margin stability above 18% as critical, and calls the near-240x P/E extreme versus peers. The latest rating is a Strong Sell at Very Strong conviction, so bearish sentiment dominates with only 9 buys offsetting 18 sells.
16 analysts rated Nebius Group in the last 30 days, with 7 Strong Buy, 4 Buy, 4 Hold and 1 Strong Sell. No articles were captured for this run. The breakdown is constructive with 11 of 16 in the buy bucket and the latest rating a Strong Buy, but the presence of a Strong Sell alongside 7 Strong Buys flags sharp polarization on the AI cloud story.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 21 analysts: 7 Strong Buy · 10 Buy · 3 Hold · 1 Sell.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 21 analysts: 6 Strong Buy · 13 Buy · 1 Hold · 1 Sell.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 11 analysts: 1 Strong Buy · 7 Buy · 1 Hold · 1 Sell · 1 Strong Sell.
19 analysts rated Palantir in the last 30 days, with 8 Strong Buy, 7 Buy, 2 Hold and 2 Sell. No article bodies were captured in this run. The 15-to-2 buy-to-sell skew and a Strong Buy latest rating keep conviction Very Strong, though the presence of 2 Sells alongside 8 Strong Buys signals real dispersion around valuation.
12 analysts rated Snowflake in the last 30 days, with 1 Strong Buy, 7 Buy, 3 Hold and 1 Sell. No article bodies were captured in this run. The 8-to-1 buy-to-sell skew and a Very Strong conviction latest rating point to a constructive tilt, with the 3 Holds representing measured caution rather than outright dissent.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 6 analysts: 1 Strong Buy · 3 Buy · 2 Hold.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 7 analysts: 1 Buy · 3 Hold · 3 Sell.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 8 analysts: 1 Strong Buy · 6 Buy · 1 Hold.
🗂️ Portfolio 2
14 analysts rated META in the last 30 days, with 3 Strong Buy, 8 Buy, 1 Hold and 2 Sell. Both new articles filed on 2026-04-21 are rated Hold: Rowan Street Capital in 'Meta Platforms: The Long Game' highlights Meta's roughly 1,300% cumulative return since IPO and notes AI video tools generating $10 billion in annual recurring revenue growing three times faster than overall advertising, while holding on near-term valuation; Justin Purohit in 'Meta Q1 Earnings Preview: AI Expansion And Its Ad Business, Shares Fairly Valued' previews the April 29 Q1 release and sees shares as reasonably priced, with Wall Street consensus at Strong Buy and a $855 price target. Despite both fresh articles landing at Hold, the broader 30-day window is strongly bullish at 11 Strong Buy or Buy versus 2 Sell, and management executive options that pay out only if Meta's stock reaches $3,727 per share by 2031 underscore long-term institutional confidence.
17 analysts rated ASML in the last 30 days, with 0 Strong Buy, 10 Buy, 6 Hold and 1 Sell. The most recent article, by Shubhm Mitessh Thakkar on 2026-04-21 at Hold, sets a price target of $1,291 against the then-closing price of $1,459.80, implying roughly 12% downside, citing Q1 beats on revenue and net income but flagging H2 2026 revenue guidance that assumes near-20% growth as optimistic and warning that potential U.S. export restrictions on DUV tools could shrink China's share of ASML revenue from 33% to around 20%. The Buy-heavy majority views ASML as a critical AI infrastructure bottleneck with a defensible EUV monopoly, while the Hold and Sell minority point to stretched valuation and China export risk as near-term overhangs.
18 analysts rated Alphabet in the last 30 days, with 3 Strong Buy, 12 Buy, 2 Hold and 1 Sell. All five captured articles date between 2026-04-08 and 2026-04-20, and four are bullish: a 2026-04-20 Buy cites 18% YoY revenue growth and 32% net income growth with Google Cloud up 48%, a 2026-04-14 Buy upgrade leans on Gemini share gains and a $240B Cloud backlog, a 2026-04-13 Buy points to the AI-powered Google Finance rollout, and a 2026-04-08 Strong Buy highlights 30%+ operating margins. A 2026-04-09 Hold is the dissent, arguing the forward PEG is 49.4% above the sector median with a $340 base-case target.
6 analysts rated ATI in the last 90 days, with 2 Strong Buy, 2 Buy and 2 Hold. Two articles landed on 2026-04-18: a Strong Buy lifting the price target to $200.83 after the prior $163.13 target was reached, citing surcharge pass-throughs and operating leverage, and a Buy crediting 32% YoY adjusted EPS growth and a 400bps HPMC margin expansion on Boeing and Airbus long-term agreements. A 2026-03-24 Hold at a $139.86 PT argues the aerospace supercycle is already priced in at ~34x forward P/E. Aerospace and defense demand is the common thread; the split is on valuation.
10 analysts rated Vertiv in the last 30 days, with 1 Strong Buy, 7 Buy and 2 Hold. Articles are uniformly bullish or constructive: a 2026-04-17 Buy sees 22-23% upside over 12-18 months on a $15B backlog and 25% 2029 EBIT margin targets, a 2026-04-14 Buy sets a $310 target arguing the 46x forward P/E yields a PEG of 1.07 cheaper than peers on growth, a 2026-04-10 Strong Buy anchors on ~$635B 2026 hyperscaler capex up 66% YoY with VRT's organic orders up 252%, and a 2026-03-17 Buy reiterates the 'pick-and-shovel' thesis. The lone dissent is a 2026-03-16 Hold downgrade after a 211% rally, noting shares are near fair value.
9 analysts rated ARM in the last 90 days, with 4 Buy, 4 Hold and 1 Sell. The most recent article, dated 2026-04-17 at Hold, argues the forward P/E near 90x prices in unrealistic growth given stagnant revenue and a $170B market cap post-51% rally. Bullish theses dated 2026-04-07, 2026-04-06 and 2026-03-25 lean on the AGI CPU opportunity (projected $1B revenue in FY27-28, $15B by 2031), 27% royalty growth and 21 CSS licenses, while a 2026-03-18 Hold was an upgrade citing resilient v9 and CSS royalty momentum. Dispersion is real: buyers are paying up for data center exposure, holders push back on valuation.
5 analysts rated Constellation Energy in the last 90 days, with 2 Buy, 1 Hold, 1 Sell and 1 Strong Sell. The most recent article on 2026-04-16 is Hold, flagging the $29B Calpine acquisition as adding over $2/share to 2026 EPS with $11-$12 guidance, and calling $250/share an attractive entry. Bullish views on 2026-03-25 and 2026-02-20 frame CEG as the nuclear backbone of AI data center demand with Microsoft, Meta, Nvidia and US government contracts, while a 2026-03-16 Sell and 2026-02-23 Strong Sell push back on Calpine-driven debt, lack of 2026 guidance clarity and zero-to-negative earnings growth. Dispersion here is unusually wide.
8 analysts rated Allstate in the last 90 days, with 1 Strong Buy, 4 Buy and 3 Hold. The most recent thesis, dated 2026-04-14 at Hold, credits disciplined underwriting, catastrophe management and an attractive sub-6x PE but flags limited premium growth, especially in auto. Bullish views include a 2026-02-27 Buy framing fair value at $240+ on 8.5x forward earnings after an 8% dividend hike and a $4B buyback, and a 2026-01-29 Strong Buy arguing ALL at roughly 6.4x earnings offers a more attractive risk-reward than Chubb. The Hold camp continues to push back on cyclical auto exposure and weather sensitivity.
11 analysts rated Arista Networks in the last 30 days, with 4 Strong Buy, 6 Buy and 1 Hold. Recent articles cluster tightly on the AI networking thesis: a 2026-04-13 Buy argues AI segment revenues will double this year and exceed 30% of total sales with vendor lock-in at Meta and Microsoft, a 2026-04-06 Strong Buy highlights the transition to 1.6 Tbps and 3.2 Tbps Ethernet switches against a 30.8% market CAGR, and a 2026-03-17 Strong Buy anchors the $3.25B AI networking target for FY2026 on 28.9% Q4 revenue growth. A 2026-03-13 Buy upgrade and a 2026-03-12 Buy on an expanding $105B TAM round out a uniformly constructive file with no Sells in the window.
16 analysts rated Super Micro Computer in the last 30 days, with 2 Strong Buy, 1 Buy, 4 Hold, 7 Sell and 2 Strong Sell, a clearly bearish breakdown. Recent articles reinforce the skew: a 2026-04-10 Sell sets fair value at $16.68 implying 28% downside on weak earnings and customer concentration, a 2026-03-31 Sell flags alleged illegal exports and a 6.4% Q2 gross margin with 63% of revenue from a single customer, and a 2026-03-26 Strong Sell argues SMCI is effectively un-analyzable given governance concerns. The lone counter is a 2026-04-07 high-risk Buy with a $36.04 target contingent on executive departures.
2 analysts rated SiTime in the last 90 days, both Hold. The 2026-04-09 Hold treats the $1.5B Renesas timing-business acquisition as an inflection point with balanced risk-reward pending Q1 2026 results, regulatory progress and refinancing terms. The 2026-03-31 Hold highlights a 60x FY2026 P/E despite the Apple internal-modem MEMS-oscillator win and the Renesas-driven revenue doubling. With all ratings Hold and no buys or sells, the consensus is neutral.
5 analysts rated Teradyne in the last 90 days, with 3 Buy and 2 Hold. The most recent Buy on 2026-04-09 highlights a ~60% YTD rally, progress toward becoming a secondary GPU test supplier likely for Nvidia, and robust 1Q 2026 guidance. A 2026-04-06 Hold argues the 49.44x forward P/E, pulled-forward upside to a $333 long-term price target and overbought technicals make the stock a Hold. A 2026-03-06 Buy and 2026-01-22 Buy both frame TER as a core AI infrastructure test and automation provider.
7 analysts rated SoundHound AI in the last 90 days, with 1 Strong Buy, 1 Buy, 3 Hold and 2 Sell. The window contains unusually sharp dispersion on the same day: on 2026-04-07, a Strong Buy upgrade cites nearly 100% FY2025 revenue growth, 100+ new deals and a $40.1M Q4'25 GAAP profit, while a Hold on the same date flags 11x forward EV/revenue versus a sector median below 3x and stock-based comp at 47.7% of revenue. A 2026-03-19 Sell pushes cash-burn concerns, while a 2026-03-13 Buy and Hold pair split on valuation at EV/Sales 13.10x.
2 analysts rated Trane Technologies in the last 90 days, a Buy and a Hold. The 2026-04-07 Hold notes Q4 2025 revenue up 5.6% YoY with strong Americas bookings but argues a 32.9x P/E well above the 5-year average leaves TT fully priced as COGS rose 7.2%. The earlier 2026-02-04 Buy upgrade leans on a forward-earnings reset to 28x, commercial HVAC orders up ~120% YoY (especially in data centers), a record $7.8B backlog, and a $545 FY28 share-price target implying 28% upside.
1 analyst rated Modine in the last 90 days, a Hold. Two captured articles show a rating change: the most recent on 2026-04-01 is a Hold downgrade flagging an EV/EBITDA of 25.44x and P/E of 43x after the January 2026 rally, with a $165s technical correction target, even as data center revenues rose 78% YoY. An earlier 2026-01-24 Buy at a $239.80 long-term target praised the capacity ramp. Direction-of-travel is a recent downgrade despite intact fundamentals.
5 analysts rated Comfort Systems USA in the last 90 days, with 2 Buy and 3 Hold. The most recent article on 2026-03-31 is Buy on a 41.7% YoY Q4 FY25 revenue surge to $2.65B and a $12B backlog that doubled, but subsequent Holds on 2026-03-26, 2026-02-10 and 2026-01-28 all argue the forward P/E around 35x already prices in the 26% EBITDA growth scenario and a DCF values shares 10-13% below market. A 2026-02-26 Buy treats the premium valuation as earned. The direction-of-travel on ratings is sideways with a slight downgrade bias.
5 analysts rated MongoDB in the last 90 days, with 2 Buy and 3 Hold. Buys dated 2026-03-31 and 2026-03-29 argue the ~40% YTD drop post-earnings is a compelling entry, citing 26.75% YoY Q4 FY26 revenue growth to $695.1M and a debt-free $2B+ cash balance. Holds on 2026-03-12 and two on 2026-02-26 push back on FY27 guidance implying just 17% growth and a premium valuation with limited near-term upside. The latest rating tilt is Hold at Strong conviction.
1 analyst rated nVent Electric in the last 90 days, a Buy. The sole article on 2026-03-25 highlights data center demand at 45% of sales heading toward 50%+ by FY26, a Systems Protection vertical growing 34% with margins above 20% anchored by liquid cooling, and models an 18% revenue growth, 22% margin, 22x EV/EBITDA scenario. Risks cited are tariff headwinds and competition.
4 analysts rated Tower Semiconductor in the last 90 days, with 1 Strong Buy, 1 Buy and 2 Hold. The most recent article on 2026-03-25 is a Hold arguing the forward PEG is 205% above the sector median despite consensus 62% 2027 YoY growth. A 2026-03-20 Buy initiates on silicon photonics leadership with 70%+ of new capacity reserved through 2028. A 2026-03-13 Strong Buy details silicon photonics revenue more than doubling from $106M in 2024 to $228M in 2025 with gross margins potentially expanding from 23% to nearly 40%. A 2026-02-11 Hold reiterates overvaluation after a 200% rally.
1 analyst rated MKS Instruments in the last 90 days, a Buy. The sole article on 2026-03-24 initiates coverage at Buy citing 22.7x FY2026 P/E undervaluation versus peers, an accelerating Electronics and Packaging segment tied to AI-related PCB demand, and manageable debt. With only one rating in the window, conviction reads Moderate.
7 analysts rated Incyte in the last 90 days, with 2 Strong Buy, 4 Buy and 1 Hold. The freshest Buy on 2026-03-22 highlights Jakafi's $3.09B 2025 sales up 11% YoY and Opzelura at $678M up 33% as the company prepares for the 2028 patent cliff. A 2026-03-17 Buy argues the market overemphasizes the cliff given non-Jakafi growth above 50% YoY, a 2026-03-16 Strong Buy anchors on 12.5x 2026 EPS and four near-term regulatory submissions, and a 2026-02-18 Buy points to the ruxolitinib franchise. The lone Hold on 2026-03-17 is a biotech portfolio piece not a direct call against INCY.
1 analyst rated Regal Rexnord in the last 90 days, a Buy. The sole article on 2026-03-21 frames the 'buy' on management's 2027 targets of $6.4-$7B revenue and $1.675B EBITDA, with RRX trading at a discount to peers and potential 15-20% annualized upside even without multiple expansion. Moderate conviction given the single rating.
3 analysts rated Carrier Global in the last 90 days, with 1 Buy and 2 Hold. Articles dated 2026-03-18 (Hold) and 2026-02-06 (Hold) argue CARR trades at a 40% discount to peer PE that is justified by 1.1% revenue growth versus 6.4% for peers, and that Q4 2025 revenue fell 6% YoY missing revised guidance. The lone Buy, also dated 2026-02-06, credits data center demand and aftermarket growth offsetting weak North American residential, with 2026 EPS growth of 8.1% to $2.80.
4 analysts rated Eaton in the last 90 days, with 2 Buy and 2 Hold, an even split. The most recent Buy, dated 2026-03-12, lowers the target to $373 citing 8% revenue CAGR to 2030 and record backlogs with 2026 growth normalization. The 2026-03-10 Hold and 2026-02-03 Hold both push back on premium valuation despite a near-$20B backlog and the pending Mobility spin-off. A 2026-02-04 Buy argues ETN is more of a value after peers have rallied.
3 analysts rated Intuitive Surgical in the last 90 days, with 2 Buy and 1 Hold. A 2026-03-12 Buy initiates with a $584.87 price target for 19% upside on recurring consumables and services and resilient operating margins. The 2026-03-11 Hold accepts ISRG's moat but argues the 63x P/E versus a 53.5 historical average warrants patience, with Buy upgrade triggers at $430-$367. A 2026-02-04 Buy cites 74% YoY Da Vinci 5 system placement growth and a view that soft 2026 procedure guidance is temporary.
1 analyst rated MasTec in the last 90 days, a Hold. The 2026-03-03 article is a downgrade to Hold after record Q4 and full-year 2025 results and 2026 revenue guidance of $17B up 19%, citing premium multiples (forward EV/EBITDA 23.7x, P/E 37x) and overbought technicals. Direction-of-travel is a very recent downgrade rather than a fundamental concern.
1 analyst rated MACOM Technology in the last 90 days, a Hold. The sole article on 2026-02-06 praises MTSI's positioning in RF semis with 24% YoY revenue growth, expanding margins and a 1.3x book-to-bill, but concludes that a forward EPS multiple above 50x leaves risk-reward unattractive. With only one rating, conviction is Moderate.
1 analyst rated AEIS in the last 90 days, a Buy. The sole covering thesis, dated 2026-01-27, flagged a 113% surge in data center revenue and strong margin expansion in Q3, arguing continued topline growth into FY26 despite temporary softness in semiconductor and industrial end markets. Valuation trades at a slight premium to the historical average but the analyst still viewed the stock as a solid buy given the growth outlook.